50jili top

Manchester United manager Ruben Amorim hailed Arsenal as one of the best set-piece teams he has ever faced following the 2-0 defeat at Arsenal. The Gunners took two points out of Liverpool’s lead at the summit of the Premier League after Jurrien Timber and William Saliba struck in the second half – both from corners – to condemn Amorim to his first defeat as United boss. The hosts’ second-half strikes took their goals-from-corners tally to 22 since the start of last season – a statistic that is unmatched by any other team in the division. Asked if Arsenal are one of the best teams he has come up against on corners, Amorim replied: “If you follow the Premier League for a long time you can see that. “They are also big players and you see every occasion when (Gabriel) Martinelli and (Bukayo) Saka have one-on-ones, a lot of times they go outside and they cross, and they know that if the cross goes well, they can score, and if it is a corner they can score, too, so we have to be better on that. “You have seen in all Arsenal games that every team have had problems with that (corners). And the difference today was the set-pieces. “You see a goal and then the momentum changed, and it is really hard for us to take the full control of the game after that.” Timber leaned into Rasmus Hojlund at the front post before diverting Declan Rice’s set-piece into the back of Andre Onana’s net after 54 minutes to send Arsenal into the lead. Thomas Partey’s header from Saka’s corner then deflected in off Saliba’s shoulder with 17 minutes left. Arteta and the club’s set-piece guru Nicolas Jover embraced on the touchline as Amorim was left with his head in his hands. The Arsenal supporters cheered raucously every time they won a corner – landing 13 in all without reply. However, Arteta moved to play down the significance of Arsenal’s set-piece threat. “We need that, but we want to be very dangerous and very effective from every angle and every phase of play,” said Arteta. “Today we could have scored from open play like we did against West Ham and Sporting. Last year we scored the most goals in the history of this football club. Arsenal have won four consecutive Premier League matches against Man Utd for the first time ever! 💫 pic.twitter.com/biv1kvsJEP — Premier League (@premierleague) December 4, 2024 “Not because of only set-pieces, but because of a lot of things that we have. We want to create individual and magic moments, too.” Arsenal’s win against United – the first time they have recorded four victories in a row against the Red Devils in the league – was their fourth in succession since the international break. They will head to Fulham on Sunday bidding to keep the momentum going. Arteta continued: “The will to win is there. We try our best to do that. We won four in a row, but it doesn’t matter. We have to go to Fulham now, try to be better than them and try win the game. “It’s every three days that we play. It’s a crazy schedule. We’re going to need everybody and to mentally be very strong.”

WOONSOCKET, R.I. , Dec. 6, 2024 /PRNewswire/ -- CVS Health Corporation ("CVS Health", NYSE: CVS) announced today the Reference Yield and Total Consideration (as summarized in the table below) to be paid in connection with the previously announced cash tender offer (the "Any and All Tender Offer") for any and all of its 4.100% Senior Notes due 2025 (the "Any and All Notes"). The Reference Yield and Total Consideration for the Any and All Notes are summarized in the tables below: Any and All Notes : Title of Notes CUSIP Number Original Issuer Principal Amount Outstanding Maturity Date UST Reference Security Bloomberg Reference Page Fixed Spread (bps) Reference Yield Total Consideration (1) 4.100% Senior Notes due 2025 126650CW8 CVS Health Corporation $950,087,000 3/25/2025 3.875% due 3/31/2025 FIT3 +25 bps 4.434 % $998.22 (1) Per $1,000 principal amount of Any and All Notes validly tendered at or prior to the Any and All Expiration Date and accepted for purchase. The Any and All Tender Offer is being made upon the terms and subject to the conditions set forth in the Offer to Purchase dated December 2, 2024 (as it may be amended or supplemented from time to time, the "Offer to Purchase"), which sets forth a more detailed description of the Any and All Tender Offer. Copies of the Offer to Purchase and the form of notice of guaranteed delivery with respect to the Any and All Notes ("Notice of Guaranteed Delivery") are available at www.dfking.com/cvs . The Any and All Tender Offer is open to all registered holders (individually, a "Holder" and collectively, the "Holders") of the Any and All Notes. The Total Consideration for each $1,000 principal amount of the Any and All Notes was determined in the manner described in the Offer to Purchase by reference to the fixed spread set forth in the table above plus the yield to maturity of the UST Reference Security set forth in the table above on the bid-side price of such UST Reference Security as of 11:00 a.m. , New York City time, on December 6, 2024 . Any and All Notes validly tendered and not validly withdrawn, or in respect of which a properly completed and duly executed Notice of Guaranteed Delivery is delivered pursuant to the guaranteed delivery procedures described in the Offer to Purchase (the "Guaranteed Delivery Procedures"), at or prior to 5:00 p.m. , New York City time, on December 6, 2024 (such date and time, as it may be extended, the "Any and All Expiration Date") (unless earlier terminated by CVS Health as described in the Offer to Purchase), that are accepted for purchase will receive the Total Consideration for the Any and All Notes. The settlement date for the Any and All Notes validly tendered at or prior to the Any and All Expiration Date, or validly tendered pursuant to the Guaranteed Delivery Procedures, and accepted for purchase is expected to be December 11, 2024 , the third business day following the Any and All Expiration Date (the "Any and All Settlement Date"). In addition to the Total Consideration for the Any and All Notes, Holders of the Any and All Notes accepted for purchase will receive accrued and unpaid interest ("Accrued Interest") on those Any and All Notes from the last interest payment date with respect to those Any and All Notes to, but not including, the Any and All Settlement Date. Holders who tender their Any and All Notes at or prior to 5:00 p.m. , New York City time, on December 6, 2024 (such date and time, as it may be extended, the "Any and All Withdrawal Deadline") may withdraw such tendered Any and All Notes at any time at or prior to the Any and All Withdrawal Deadline. Following the Any and All Withdrawal Deadline, Holders who have tendered their Any and All Notes may not withdraw such Any and All Notes unless CVS Health is required to extend withdrawal rights under applicable law. CVS Health expressly reserves the right, in its sole discretion, subject to applicable law, to amend, extend or terminate the Any and All Tender Offer at any time prior to the Any and All Expiration Date. The Any and All Tender Offer is not conditioned on any minimum principal amount of Any and All Notes being tendered but the Any and All Tender Offer is subject to a financing condition and certain other general conditions as described in the Offer to Purchase. CVS Health has retained Barclays Capital Inc. and Mizuho Securities USA LLC to act as Dealer Managers for the Tender Offers (as defined in the Offer to Purchase). D.F. King & Co., Inc. has been retained to act as the Tender and Information Agent for the Tender Offers. The Offer to Purchase and, in connection with the Any and All Notes, the Notice of Guaranteed Delivery may be accessed at the following link: http://www.dfking.com/cvs . Requests for assistance relating to the procedures for tendering Notes (as defined in the Offer to Purchase) may be directed to the Tender and Information Agent either by email at cvs@dfking.com , or by phone (212) 269-5550 (for banks and brokers only) or (800) 487-4870 (for all others toll free). Requests for assistance relating to the terms and conditions of the Tender Offers may be directed to Barclays Capital Inc. at (800) 438-3242 (toll free) or (212) 528-7581 (collect) or Mizuho Securities USA LLC at (866) 271-7403 (toll-free) or (212) 205-7741. Beneficial owners may also contact their broker, dealer, commercial bank, trust company or other nominee for assistance. This press release does not constitute an offer to sell or purchase, or a solicitation of an offer to sell or purchase, or the solicitation of tenders with respect to, the Notes. No offer, solicitation, purchase or sale will be made in any jurisdiction in which such an offer, solicitation, or sale would be unlawful. The Tender Offers are being made solely pursuant to the Offer to Purchase made available to Holders of the Notes. None of CVS Health, the Dealer Managers, Tender and Information Agent or the trustees with respect to the Notes, or any of their respective affiliates, is making any recommendation as to whether or not Holders should tender or refrain from tendering all or any portion of their Notes in response to the Tender Offers. Holders are urged to evaluate carefully all information in the Offer to Purchase, consult their own investment and tax advisers and make their own decisions whether to tender Notes in the Tender Offers, and, if so, the principal amount of Notes to tender. About CVS Health CVS Health is a leading health solutions company building a world of health around every consumer it serves and connecting care so that it works for people wherever they are. As of September 30, 2024 , the Company had more than 9,000 retail locations, more than 900 walk-in medical clinics, more than 225 primary care medical clinics, a leading pharmacy benefits manager with approximately 90 million plan members and expanding specialty pharmacy solutions, and a dedicated senior pharmacy care business serving more than 800,000 patients per year. The Company also serves an estimated more than 36 million people through traditional, voluntary and consumer-directed health insurance products and related services, including expanding Medicare Advantage offerings and a leading standalone Medicare Part D prescription drug plan. The Company is creating new sources of value through its integrated model allowing it to expand into personalized, technology driven care delivery and health services, increasing access to quality care, delivering better health outcomes and lowering overall health care costs. Forward-Looking Statements This press release contains forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of CVS Health. By their nature, all forward-looking statements are not guarantees of future performance or results and are subject to risks and uncertainties that are difficult to predict and/or quantify. Actual results may differ materially from those contemplated by the forward-looking statements due to the risks and uncertainties described in our Securities and Exchange Commission filings, including those set forth in the Risk Factors section and under the heading "Cautionary Statement Concerning Forward-Looking Statements" in our most recently filed Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q for the quarterly periods ended March 31, 2024 , June 30, 2024 and September 30, 2024 and our Current Reports on Form 8-K. You are cautioned not to place undue reliance on CVS Health's forward-looking statements. CVS Health's forward-looking statements are and will be based upon management's then-current views and assumptions regarding future events and operating performance, and are applicable only as of the dates of such statements. CVS Health does not assume any duty to update or revise forward-looking statements, whether as a result of new information, future events, uncertainties or otherwise. Investor Larry McGrath Media Ethan Slavin Contact: Executive Vice President Contact: 860-273-6095 Chief Strategy Officer & Ethan.Slavin@CVSHealth.com Chief Strategic Advisor to the CEO investorinfo@cvshealth.com View original content to download multimedia: https://www.prnewswire.com/news-releases/cvs-health-corporation-announces-pricing-of-any-and-all-tender-offer-302325192.html SOURCE CVS HealthTORONTO — , a leading provider of conversational AI solutions for inbound telephone call management, is pleased to announce that it has commenced the Service Organization Control (“ ”) 2 Type I certification process. This significant milestone underscores Syntheia’s commitment to safeguarding customer data and upholding the highest standards of security and privacy. As part of this initiative, on October 18, 2024, Syntheia engaged Vanta Inc. (“ ”), a leader in continuous security monitoring and compliance automation. Leveraging Vanta’s platform, Syntheia is streamlining its SOC 2 Type I certification journey with real-time adherence to security best practices and the ability to identify risks before they escalate. This collaboration demonstrates Syntheia’s proactive approach to meeting stringent compliance requirements while delivering secure, reliable AI solutions to its customers. As a conversational AI SaaS platform, Syntheia leverages advanced Natural Language Processing (NLP) technology to create virtual assistants that act as responsive, intelligent receptionists for businesses. With an increasing volume of sensitive data exchanged in customer interactions, data protection has become a critical priority. Achieving SOC 2 Type I certification will further enhance Syntheia’s ability to secure and protect customer information. “Syntheia understands the importance of data security in today’s digital landscape, and it’s our top priority to maintain the trust of our clients,” said Paul Di Benedetto, Chief Technology Officer at Syntheia. “Starting the SOC 2 Type I certification process represents our dedication to transparency and accountability, as we work tirelessly to ingrain data privacy measures into every aspect of our operations.” SOC 2, developed by the American Institute of CPAs (AICPA), is widely recognized as a benchmark for data security, evaluating an organization’s information systems and their adherence to essential trust principles such as security, availability, and confidentiality. By undergoing this rigorous certification, Syntheia aims to provide clients with enhanced confidence in the resilience of its platform against data breaches and unauthorized access. The SOC 2 Type I certification journey reflects Syntheia’s ongoing commitment to delivering secure and reliable AI solutions. For more information about Syntheia and its data privacy initiatives, visit For more information, visit Syntheia is an artificial intelligence technology company which is developing and commercializing proprietary algorithms to deliver human-like conversations. Our SaaS platform offers conversational AI solutions for both enterprise and small-medium business customers globally. Tony Di Benedetto Chief Executive Officer Tel: (844) 796-8434Ross Halls takes look at how Ipswich Town players got on for their loan clubs in midweek. FABULOUS FROM FOYO 😍 Osman Foyo found the top corner excellent with this brilliant finish, rounding off a good move from a quick free kick! #ClaretsTogether pic.twitter.com/AH6kh1RjVy OSMAN FOYO AND WOODY WILLIAMSON Foyo notched his ninth goal for Chelmsford City as they won 3-2 at Billericay Town in the Essex Senior Cup. Williamson wasn't involved for Robbie Simpson's side, who booked their place in the quarter finals of the competition. The Clarets switch their focus back to league action as they host Slough Town in the National League South on Saturday. GEORGE EDMUNDSON The defender featured for Middlesbrough as they were beaten 1-0 at home by Blackburn Rovers in the Championship. Edmundson played the full 90 minutes for Michael Carrick's side, who suffered their first defeat in three games, but remain in the play-off spots. Boro will look to bounce back when they host Hull City on Saturday. Marcus Harness in action for Derby County. (Image: PA) MARCUS HARNESS The attacker featured for Derby County as they lost 2-1 at home to Swansea City in the second tier. Harness started and played 79 minutes for Paul Warne's side, who saw their three-game unbeaten run come to an end and slip down to 15th in the table. The Rams will look to return to winning ways when they host Sheffield Wednesday on Sunday. ELKAN BAGGOTT The defender wasn't involved for Blackpool as they won 2-0 at Bristol Rovers in the third tier. Baggott has a thigh problem which has him sidelined for Steve Bruce's side, who ended an eight league match winless streak. Former Town midfielder Lee Evans netted from the spot. The Seasiders switch their focus to cup action as they host Birmingham City in the second round of the FA Cup. 🪩 TEN wins in a row! pic.twitter.com/RPhJeOJ65r CAMERON HUMPHREYS The midfielder featured for Wycombe Wanderers as they beat Mansfield Town 1-0 at Adams Park in League One. Humphreys played the full 90 minutes for Matt Bloomfield's side, who made it 14 games unbeaten in the league, thanks to a 93rd minute winner from Luke Leahy. The Chairboys remain top of the table, four points clear of second-place Wrexham and switch their focus to FA Cup action when they travel to non-league side Wealdstone in the second round. FINLEY BARBROOK AND EDWIN AGBAJE Barbrook played the full 90 minutes and was booked for Sutton United as they beat Solihull Moors 1-0 at home in the National League. Agbaje wasn't involved for Steve Morison's side as the defender recovers from his most recent injury set-back. The U's made it back-to-back league wins and return to action when they host Fylde on Saturday. FULL TIME: @leistonfc 2 @OFCLTRAWLERBOYS 1 The hosts progress in this @EndeavourAutom @SuffolkFA Premier Cup Second Round tie - with three goals scored in a four minute spell early in the second half, as Harry Barbrook was on target with The Trawlerboys equaliser #LTFC pic.twitter.com/immCuPnQqA HARRY BARBROOK The young full-back scored for Lowestoft Town as they lost 2-1 at Leiston in the Suffolk Premier Cup. Barbrook notched his second goal for Andy Reynolds' side, who were knocked out of the second round of the competition. The Trawler Boys switch their focus back to league action when they travel to Banbury United in the Southern League Premier Central on Saturday. LEON AYINDE The Irishman wasn't involved for Rochdale as they won 1-0 at promotion rivals Gateshead in the National League. Ayinde is close to returning for Jimmy McNulty's side after recovering from a hamstring injury last month. The Dale are sixth in the table and aren't back in action until they host Manchester United U21s in the National League Cup next Tuesday. NICO VALENTINE The youngster wasn't involved for Needham Market as they won 1-0 at Leamington in the National League North. Valentine is currently out of action with a hamstring injury for Kevin Horlock's side, who secured their first victory in eight league games, thanks to a Nick Ingram penalty. The Marketmen are now off the bottom of the table, moving to 23rd and return to action when they host Scarborough Athletic on Saturday. He is magic, you know 😉 pic.twitter.com/YcwRcQSoJ6 EX-BLUES CORNER Jeremy Sarmiento opened the scoring for Burnley as they beat Coventry City 2-0 at Turf Moor in the Championship. The Brighton loanee has two league goals this season so far. Josh Earl scored for Barnsley as they drew 2-2 with Reading at Oakwell in League One. The defender's first goal in over a year and his maiden goal for the Tykes. James Norwood was among the scorers for Oldham Athletic as they beat Boston United 4-0 at Boundary Park in the National League. The forward has notched seven goals in 14 games in all competitions so far this season.

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)